Resumen
Candida parapsilosis is considered to be a complex of three
species due to genetic heterogeneity. Currently, it is the second most isolated yeast in
bloodstream infections and oral cavity sites with C. parapsilosis sensu stricto and C.
metapsilosis being the species mostly recovered from oral niches in both healthy and
immunecompromised patients respectively. Disparity in antifungal susceptibility has been
reported among species of this complex, while no data on distribution and behavior in the
oral cavity has been reported in Argentina.
Objective: To molecularly characterize a collection of isolates from Argentina,
phenotypically identified as C. parapsilosis from different oral niches, in a cohort of
patients with different oral and dental clinical conditions.
Methodology: This experimental study used 31 yeasts phenotypically recognized as C.
parapsilosis and recovered for molecular characterization by end-point PCR using specific
primers. The in vitro sensitivity of isolates against azoles, echinocandins, amphotericin
and flucytosine was evaluated by automated Vitek2 system and MIC (Minimum Inhibitory
Concentration) in line with CLSI (Clinical and Laboratory Standards Institute) M27-A3
guidelines.
Results: All isolates, 100% (31/31), were positive for C. parapsilosis sensu stricto
species. Of these, 77.4% were recovered in oral inflammatory conditions, and 94.7% of the
strains analyzed for antifungal susceptibility profile showed favorable response to all
drugs tested.
Conclusions: C. parapsilosis sensu strictois a common colonizing of the oral mucosa under
pathological conditions, and generally shows favorable response to antifungal agents
commonly used in clinical practice, but with a tendency to lower responsiveness to azoles
and echinocandins.
| Idioma original | Español |
|---|---|
| Publicación | Journal of Dental Science and Therapy |
| Estado | Publicada - 2016 |
| Publicado de forma externa | Sí |
Palabras clave
- Candida parapsilosis complex; Periodontal disease; Minimum inhibitory concentration; Clinical and laboratory institute